Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Sub-committee seeks assurances for NI medicine supplies
Restrictions would primarily affect the farming industry, but also impacts show animals.
Letter to UK government calls for solution between UK and EU.

An inquiry has prompted a sub-committee to write to the UK government with concerns about Northern Ireland’s future veterinary medicine access.

The sub-committee says that, with Northern Ireland posed to lose access to currently used medicines, a swift solution between the UK and EU is needed to protect animal health.

Northern Ireland is currently in a grace period until December 2025 for veterinary medicines. However, if no solution is found, it will have to comply with full European Union regulations.

The Sub-Committee on the Windsor Framework launched its inquiry in January, examining how EU Veterinary Medicinal Products Regulation would affect Northern Ireland and its veterinary industry. It also considered the effects of no solution.

The committee spoke with a range of stakeholders, including veterinary professionals, academics and the government.

Findings revealed that, without a solution, Northern Ireland risked losing access to approximately a third of its currently used veterinary medicines after the grace period. This could not only affect companion animals, equine and farm animals, but also human health.

The restrictions would primarily affect the farming industry, making it harder for farmers to sell produce and further risking public health. Discussions found that rural economy was considered essential to Northern Ireland, so restrictions and associated costs could cause social and economic consequences.

However there were also concerns for show animals, such as horses and companion animals, that would not receive the necessary vaccinations to compete in events such as the Olympics.

The committee has asked that the government provides an updated assessment of medicines which could be discontinued, as well as an assessment on the reduction of medicines for human health and the food supply chain.

It has also called for an analysis of the potential economic consequences of this reduction in availability, and an update on the progress made in reaching a solution.

Lord Jay of Ewelme, chair of The Windsor Framework Sub-Committee, said: “We have set out some solutions proposed by our witnesses.

“They were united on the importance of political will in resolving this crucial issue, and the urgency in doing so, and we endorse their call for talks leading to a mutually-agreed solution between the UK and the EU as soon as possible.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.